DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Houk BE, Bello CL, Michaelson MD, Bukowski RM, Redman BG, Hudes GR, Wilding G, Motzer RJ.
Exposure-response of sunitinib in metastatic renal cell
carcinoma (mRCC): A population pharmacokinetic/pharmacodynamic (PKPD)
approach.
J Clin Oncol 2007; 25
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.